Ladenburg Thalmann Comments On Seracare Life Sciences Bid

According to Ladenburg Thalmann, Seracare Life Sciences SRLS and been the subject of an unsolicited $4.25 offer. Ladenburg Thalmann said that on 6/23/11, an investor group disclosed an unsolicited bid to acquire SRLS for $4.25 per share in cash with a deadline of 5:00 PM EST 7/11/11 for SRLS to respond to its offer and until 7/29/11 to enter a definitive merger agreement. “Reiterating Neutral rating.” Seracare Life Sciences closed on Friday at $3.90.